355 related articles for article (PubMed ID: 23685223)
1. Assessment of apoB dyslipoproteinemia in Korean population.
Moon HW; Park CM; Hong SN; Park S; Hur M; Yun YM
Clin Biochem; 2013 Aug; 46(12):1041-1046. PubMed ID: 23685223
[TBL] [Abstract][Full Text] [Related]
2. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
3. Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.
Martinez-Hervas S; Real JT; Priego MA; Carratalá A; Sniderman AD; Carmena R; Ascaso JF
Int J Clin Pract; 2013 Jan; 67(1):81-8. PubMed ID: 23241052
[TBL] [Abstract][Full Text] [Related]
4. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines.
Sathiyakumar V; Park J; Quispe R; Elshazly MB; Michos ED; Banach M; Toth PP; Whelton SP; Blumenthal RS; Jones SR; Martin SS
Circulation; 2018 Jul; 138(3):244-254. PubMed ID: 29506984
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
[TBL] [Abstract][Full Text] [Related]
6. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.
Ying X; Qian Y; Jiang Y; Jiang Z; Song Z; Zhao C
Acta Diabetol; 2012 Dec; 49(6):465-72. PubMed ID: 22965469
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
8. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
[TBL] [Abstract][Full Text] [Related]
9. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
Du Y; Sun H; Li Y; Shi X; Pei D; Qi D; Wang B
Clin Lab; 2014; 60(8):1295-300. PubMed ID: 25185414
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.
Whelton SP; Meeusen JW; Donato LJ; Jaffe AS; Saenger A; Sokoll LJ; Blumenthal RS; Jones SR; Martin SS
J Clin Lipidol; 2017; 11(4):1065-1072. PubMed ID: 28826567
[TBL] [Abstract][Full Text] [Related]
11. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
[TBL] [Abstract][Full Text] [Related]
12. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
[TBL] [Abstract][Full Text] [Related]
13. Low bone mineral density is associated with dyslipidemia in South Korean men: the 2008-2010 Korean National Health and Nutrition Examination Survey.
Kim YH; Nam GE; Cho KH; Choi YS; Kim SM; Han BD; Han KD; Lee KS; Park CH; Kim DH
Endocr J; 2013; 60(10):1179-89. PubMed ID: 23877056
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
[TBL] [Abstract][Full Text] [Related]
15. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
[TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
Tóth PP; Potter D; Ming EE
J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
[TBL] [Abstract][Full Text] [Related]
18. Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns.
Katulanda GW; Katulanda P; Adler AI; Peiris SR; Draisey I; Wijeratne S; Sheriff R; Matthews DR; Shine B
Ann Clin Biochem; 2010 Jan; 47(Pt 1):29-34. PubMed ID: 19952033
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB.
Sniderman AD; Toth PP; Thanassoulis G; Furberg CD
J Clin Lipidol; 2016; 10(5):1248-58. PubMed ID: 27678443
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
